Trial intelligence / Profile preview

Varenicline vs NRT on Smoking Cue Reactivity

NCT02551692Completed

Sponsor
Duke University
Start
Jan 2016
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of varenicline in nicotine dependence (3 arms), sponsored by Duke University. Primary endpoints: Change in Craving Score During Cue Exposure Task, Change in Latency to Smoke During Cue Exposure Task and 1 more. Started Jan 2016; status: completed.

02

Drugs

varenicline
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT02551692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02551692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call